Retractable Technologies (RVP) AI Stock Analysis

• Market Cap: $20.71M
• Dividend Yield: N/A
• Average Volume (3M): 51.24K
• Price to Earnings (P/E): ―
• Beta (1Y): 0.71
• Revenue Growth: -16.05%
• EPS Growth: -195.28%
• Country: US
• Employees: 221
• Sector: Healthcare
• Sector Strength: 58
• Industry: Medical - Instruments & Supplies
• EPS (TTM): -0.35
• Shares Outstanding: 29,937,159
• 10 Day Avg. Volume: 25,876
• 30 Day Avg. Volume: 51,242
• PEG Ratio: -0.12
• Price to Book (P/B): 0.51
• Price to Sales (P/S): 0.00
• P/FCF Ratio: -870.93
• Enterprise Value/Market Cap: 1.74
• Enterprise Value/Revenue: 0.25
• Enterprise Value/Gross Profit: -12.30
• Enterprise Value/Ebitda: -6.74
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0

• Rating: 46 Neutral
• Price Target: $0.50 ▼(-23.08%Downside)

The overall score is primarily impacted by weak financial performance and valuation concerns, due to declining revenues, negative margins, and lack of profitability. Technical analysis reflects bearish sentiment, while positive corporate governance events provide some support. Improvement in operational performance and profitability is crucial for a better outlook.

Retractable Technologies Business Overview & Revenue Model

Company Description

Retractable Technologies, Inc. designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. It offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes. The company distributes its products through general line and specialty distributors, as well as through international distributors; and a direct marketing network. Retractable Technologies, Inc. was incorporated in 1994 and is headquartered in Little Elm, Texas.

How the Company Makes Money

Retractable Technologies generates revenue through the sale of its safety-engineered medical products, particularly its retractable safety syringes. The company sells these products to healthcare providers, hospitals, and clinics, as well as through distribution partnerships with medical supply companies. Revenue is driven by product sales, and any significant partnerships with large healthcare organizations or distributors can have a substantial impact on earnings. The adoption of safety regulations and standards in healthcare settings that prioritize needlestick prevention also serves as a critical factor contributing to the company's revenue growth.

Retractable Technologies Financial Statement Overview

Summary

Retractable Technologies is facing significant financial challenges with declining revenues and negative margins, indicating operational issues. The balance sheet is stable with low leverage, but negative cash flows highlight liquidity concerns.

Income Statement

The revenue has shown a significant decline from 2021 to TTM (Trailing-Twelve-Months), dropping from $188M to $33.7M. The gross profit margin has turned negative in TTM, indicating cost issues or pricing pressures. Net and EBIT margins are also negative, highlighting ongoing profitability challenges. Despite previous profitability in 2021, the recent trend indicates financial distress.

Balance Sheet

The company's debt levels are low relative to equity, with a debt-to-equity ratio well under 1, indicating limited leverage risk. However, stockholders' equity has decreased over the periods, reflecting erosion of value. The equity ratio remains strong, suggesting a solid asset base relative to liabilities.

Cash Flow

The operating cash flow is negative in TTM, indicating the company is struggling to generate cash from operations. Free cash flow is also negative, reflecting challenges in maintaining liquidity. Historical free cash flow was volatile, and recent trends show deterioration, posing risks to financial stability.

Breakdown
TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement		Total Revenue
33.75M	33.05M	43.60M	94.82M	188.38M	81.86M
	Gross Profit
-2.93M	-1.03M	9.11M	28.25M	95.35M	37.01M
	EBIT
-22.80M	-21.11M	-11.49M	2.99M	72.60M	24.07M
	EBITDA
-6.57M	4.17M	-1.24M	9.94M	76.44M	27.17M
	Net Income Common Stockholders
-22.82M	-11.89M	-7.01M	5.08M	56.06M	24.22M
Balance Sheet		Cash, Cash Equivalents and Short-Term Investments
3.38M	44.56M	47.29M	49.38M	42.43M	25.65M
	Total Assets
149.31M	160.72M	179.67M	195.67M	206.30M	104.97M
	Total Debt
343.22K	1.23M	1.54M	1.82M	2.10M	3.74M
	Net Debt
-3.04M	-3.00M	-11.13M	-17.90M	-27.06M	-13.83M
	Total Liabilities
72.70M	73.55M	80.38M	89.13M	107.14M	55.09M
	Stockholders Equity
76.61M	87.17M	99.29M	106.54M	99.17M	49.88M
Cash Flow		Free Cash Flow
-12.31M	-13.00M	1.91M	-61.95K	-25.57M	-2.05M
	Operating Cash Flow
-11.01M	-11.56M	2.77M	16.77M	32.79M	19.00M
	Investing Cash Flow
4.93M	3.66M	-10.76M	-31.20M	-63.04M	-19.33M
	Financing Cash Flow
-543.70K	-535.43K	941.64K	4.99M	41.84M	11.96M

Retractable Technologies Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 0.65
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For RVP, the sentiment is Negative. The current price of 0.65 is below the 20-day moving average (MA) of 0.67, below the 50-day MA of 0.70, and below the 200-day MA of 0.74, indicating a bearish trend. The MACD of -0.01 indicates Negative momentum. The RSI at 40.41 is Neutral, neither overbought nor oversold. The STOCH value of 60.26 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for RVP.

Retractable Technologies Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
MHUA	66 Neutral	$12.04M	0.94	7.10%	―	-0.19%	-18.41%
Sector *	54 Neutral	$5.41B	3.27	-45.10%	3.29%	16.81%	0.02%
AKYA	47 Neutral	$62.84M	―	-354.27%	―	-14.55%	34.87%
RVP	46 Neutral	$20.71M	―	-25.89%	―	-16.05%	-195.28%
MLSS	44 Neutral	$69.86M	―	-88.36%	―	-9.13%	30.04%
FEMY	38 Underperform	$24.78M	―	-239.87%	―	61.97%	-6.89%
STSS		$6.00M	―	-75.14%	―	―	―

Retractable Technologies Corporate Events

Retractable Technologies Settles Lawsuit with Locke Lord LLP

On May 19, 2025, Retractable Technologies, Inc. entered into a Settlement Agreement resolving all claims in a lawsuit against Locke Lord LLP in the 44th District Court of Dallas County, Texas. The lawsuit involved allegations related to legal representation in previous litigation against Becton, Dickinson and Company. The settlement results in Retractable Technologies receiving $1.9 million, dismissing all claims with prejudice, and exchanging mutual releases with the defendants, with no admission of liability or damages by either party.

Retractable Technologies Holds Successful Shareholder Meeting

During the virtual Annual Meeting of Shareholders on May 9, 2025, Retractable Technologies, Inc. successfully elected three Class 1 directors and obtained shareholder approval for executive compensation. Additionally, shareholders decided that future advisory votes on executive compensation will occur every three years, aligning with the company’s strategic governance practices. These decisions are likely to impact the company’s operational governance and reflect shareholder confidence in the current management and strategic direction.